This document discusses infection control, biosafety, and first aid. It covers key topics like the chain of infection, breaking the chain of infection through proper hand hygiene and use of personal protective equipment, isolation procedures, bloodborne pathogens, and OSHA regulations regarding exposure to bloodborne pathogens. The objectives are to demonstrate knowledge of infection control practices, identify safety hazards and regulations, recognize first aid needs, and describe the importance of personal wellness.
This document discusses blood collection equipment, additives, and order of draw. It describes the general equipment needed, including phlebotomy chairs, carts, gloves, antiseptics, and sharps containers. It also details venipuncture equipment such as vein locators, tourniquets, needles of various gauges and lengths, and evacuated tube systems versus syringe systems. Blood collection additives like anticoagulants and clot activators are explained. The importance of the correct order of draw is emphasized to minimize contamination between test tubes.
This document outlines the steps for performing venipuncture, which is the process of collecting blood from a vein. It describes the 19 steps of venipuncture in detail, from reviewing the test request to transporting the specimen to the lab. Key steps include properly identifying the patient, selecting and preparing the vein, inserting and anchoring the needle, filling collection tubes in the correct order, and applying pressure after removing the needle. Special considerations for patients like pediatrics, geriatrics, and those requiring dialysis are also addressed.
This document discusses infection control, biosafety, and first aid. It covers key topics like the chain of infection, breaking the chain of infection through proper hand hygiene and use of personal protective equipment, isolation procedures, bloodborne pathogens, and OSHA regulations regarding exposure to bloodborne pathogens. The objectives are to demonstrate knowledge of infection control practices, identify safety hazards and regulations, recognize first aid needs, and describe the importance of personal wellness.
This document discusses blood collection equipment, additives, and order of draw. It describes the general equipment needed, including phlebotomy chairs, carts, gloves, antiseptics, and sharps containers. It also details venipuncture equipment such as vein locators, tourniquets, needles of various gauges and lengths, and evacuated tube systems versus syringe systems. Blood collection additives like anticoagulants and clot activators are explained. The importance of the correct order of draw is emphasized to minimize contamination between test tubes.
This document outlines the steps for performing venipuncture, which is the process of collecting blood from a vein. It describes the 19 steps of venipuncture in detail, from reviewing the test request to transporting the specimen to the lab. Key steps include properly identifying the patient, selecting and preparing the vein, inserting and anchoring the needle, filling collection tubes in the correct order, and applying pressure after removing the needle. Special considerations for patients like pediatrics, geriatrics, and those requiring dialysis are also addressed.
This document discusses cancer stem cells (CSCs), which are rare cells in tumors that have the ability to self-renew and differentiate into the diverse cells that comprise the tumor. CSCs were first hypothesized in the 1870s and experiments in the 1950s-60s provided early evidence for their existence. The concept of CSCs was revived in the 2000s, with the definition that they can recapitulate tumor growth. CSCs are identified experimentally by markers and assays. They are thought to originate from somatic or adult stem/progenitor cells and have properties of self-renewal, differentiation, immortality. CSCs may cause metastases, therapy resistance and recurrence. Targeting CSCs may improve cancer treatment and CSCs may serve
This document discusses cancer stem cells (CSCs), which are rare cells in tumors that have the ability to self-renew and differentiate into the diverse cells that comprise the tumor. CSCs were first hypothesized in the 1870s and experiments in the 1950s-60s provided early evidence for their existence. The concept of CSCs was revived in the 2000s, with the definition that they can recapitulate tumor growth. CSCs are identified experimentally by markers and assays. They are thought to originate from somatic or adult stem/progenitor cells and have properties of self-renewal, differentiation, immortality. CSCs may cause metastases, therapy resistance and recurrence. Targeting CSCs may improve cancer treatment and CSCs may serve
1. ŁUKASZ FUŁAWKA
ZABURZENIA KRĄŻENIA cz. I
OBRZĘK, PRZEKRWIENIE
Dolnośląskie Centrum Onkologii
Zakład Patomorfologii
Uniwersytet Medyczny we Wrocławiu
Zakład Patomorfologii i Cytologii Onkologicznej
